[1]KAMAR N, BENDALL R, LEGRAND-ABRAVANEL F, et al Hepatitis E[J].Lancet, 2012, 379 (9835) :2477-2488.
|
[2]AGGARWAL R.Hepatitis E:epidemiology and natural history[J].J Clin Exp Hepatol, 2013, 3 (2) :125-133.
|
[3]ZHU FC, HUANG SJ, WU T, et al.Epidemiology of zoonotic hepatitis E:a community-based surveillance study in a rural population in China[J].PLoS One, 2014, 9 (1) :e87154.
|
[4]TRINCHIERI G.Biology of natural killer cells[J].Adv Immunol, 1989, 47:187-376.
|
[5]PARHAM P, NORMAN P J, ABI-RACHED L, et al.Humanspecific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex classⅠmolecules[J].Philos Trans R Soc Lond B Biol Sci, 2012, 367 (1590) :800-811.
|
[6]JAMIL KM, KHAKOO SI.KIR/HLA interactions and pathogen immunity[J].J Biomed Biotechnol, 2011, 2011:298348.
|
[7]KULKARNI S, MARTIN MP, CARRINGTON M.KIR genotyping by multiplex PCR-SSP[J].Methods Mol Biol, 2010, 612:365-375.
|
[8]PARHAM P, MOFFETT A.Variable NK cell receptors and their MHCclassⅠligands in immunity, reproduction and human evolution[J].Nat Rev Immunol, 2013, 13 (2) :133-144.
|
[9]SIPS M, LIU Q, DRAGHI M, et al.HLA-C levels impact natural killer cell subset distribution and function[J].Hum Immunol, 2016, 77 (12) :1147-1153.
|
[10]KHAKOO SI, THIO CL, MARTIN MP, et al.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection[J].Science, 2004, 305 (5685) :872-874.
|
[11]AHLENSTIEL G, MARTIN M P, GAO X, et al.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses[J].J Clin Invest, 2008, 118 (3) :1017-1026.
|
[12]O'CONNOR GM, VIVIAN JP, WIDJAJA JM, et al.Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity[J].JImmunol, 2014, 192 (6) :2875-2884.
|
[13]BOUDREAU JE, MULROONEY TJ, le LUDUEC JB, et al.KIR3 DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV[J].J Immunol, 2016, 196 (8) :3398-3410.
|
[14]YUSA S, CATINA TL, CAMPBELL KS.KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) [J].J Immunol, 2004, 172 (12) :7385-7392.
|
[15]CAULI A, PIGA M, DESSOLE G, et al.Killer-cell immunoglobulin-like receptors (KIR) and HLA-classⅠheavy chains in ankylosing spondylitis[J].Drug Dev Res, 2014, 75 (Suppl 1) :s15-s19.
|
[16]ZHOU L, LI XY, HUANG YH.Regulatory effect of interleukin-10 on natural killer cells in patients with chronic hepatitis B[J].J Clin Hepatol, 2016, 32 (8) :1600-1603. (in Chinese) 周亮, 李小燕, 黄月华.白细胞介素10对慢性乙型肝炎患者自然杀伤细胞的调控作用[J].临床肝胆病杂志, 2016, 32 (8) :1600-1603.
|